Andreas Kjær

Søgeresultater

• 2015

  New 177-lutetium labeled urokinase-type plasminogen activator receptor binding peptide conjugate, useful for treating cancer such as colorectal cancer, prostate cancer, neuroendocrine tumors, brain tumors, breast tumors and ovarian tumors

  Kjaer, A., Persson, M. & Ploug, M., 8 jul. 2015, IPC nr. C07K 16/ 30 A I, Patentnr. CN104768573, Prioritetsdato 3 maj 2013, Prioritetsnr. WO2013DK50126

  Publikation: Patent
• 2012

  Entrapment of radionuclides in nanoparticle compositions

  Kjær, A., 2012, Patentnr. 2012079582, 22 jun. 2012

  Publikation: Patent
• 2011

  Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition.

  Kjær, A., 2011, Patentnr. WO2011006510-A1

  Publikation: Patent